Literature DB >> 11512523

Apoptosis: mediator or mode of cell killing by anticancer agents?

J M Brown1, B G Wouters.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11512523     DOI： 10.1054/drup.2001.0193

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN： 1368-7646            Impact factor:   18.500


× No keyword cloud information.
  8 in total

Review 1.  Pathologies associated with the p53 response.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-07       Impact factor: 10.005

2.  Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer.

Authors:  Li Pan; Xing-Chen Peng; Fei Leng; Qing-Zhong Yuan; Yan Shan; Dan-Dan Yu; Zhi-Yong Li; Xiang Chen; Wen-Jing Xiao; Yuan Wen; Tian-Tai Ma; Li Yang; Yong-Qiu Mao; Han-Shuo Yang; Yu-Quan Wei; Chun-Ting Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

Review 3.  HtrA serine proteases as potential therapeutic targets in cancer.

Authors:  Jeremy Chien; Mara Campioni; Viji Shridhar; Alfonso Baldi
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

4.  Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis.

Authors:  Sylvia Mansilla; Benjamin Piña; José Portugal
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

Review 5.  Cell death and deubiquitinases: perspectives in cancer.

Authors:  Seemana Bhattacharya; Mrinal Kanti Ghosh
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

6.  The role of apoptotic cell death in the radiosensitising effect of gemcitabine.

Authors:  B Pauwels; J B Vermorken; A Wouters; J Ides; S Van Laere; H A J Lambrechts; G G O Pattyn; K Vermeulen; P Meijnders; F Lardon
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

7.  Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance.

Authors:  Janine T Erler; Christopher J Cawthorne; Kaye J Williams; Marianne Koritzinsky; Bradley G Wouters; Clare Wilson; Crispin Miller; Costas Demonacos; Ian J Stratford; Caroline Dive
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells.

Authors:  N Dunlap; G G Schwartz; D Eads; S D Cramer; A B Sherk; V John; C Koumenis
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.